Cargando…

ZNF121 interacts with ZBRK1 and BRCA1 to regulate their target genes in mammary epithelial cells

The novel zinc finger protein 121 (ZNF121) has been demonstrated to physically and functionally associate with the MYC oncoprotein to regulate cell proliferation and likely breast cancer development. To further understand how ZNF121 functions in cell proliferation and carcinogenesis, we identified a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Ang, Zhang, Kailun, Zhao, Yanxia, Zhu, Zhengmao, Fu, Liya, Dong, Jin‐Tang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275281/ https://www.ncbi.nlm.nih.gov/pubmed/30524945 http://dx.doi.org/10.1002/2211-5463.12530

Ejemplares similares

Correlation between ZBRK1/ZNF350 gene polymorphism and breast cancer
por: Wu, Jun, et al.
Publicado: (2021)

PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer
por: Yeerken, Danna, et al.
Publicado: (2020)

Preventing BRCA1/ZBRK1 repressor complex binding to the GOT2 promoter results in accelerated aspartate biosynthesis and promotion of cell proliferation
por: Hong, Ruoxi, et al.
Publicado: (2019)

Corrigendum to: Preventing BRCA1/ZBRK1 repressor complex binding to the GOT2 promoter results in accelerated aspartate biosynthesis and promotion of cell proliferation
Publicado: (2020)

Loss of ZBRK1 Contributes to the Increase of KAP1 and Promotes KAP1-Mediated Metastasis and Invasion in Cervical Cancer
por: Lin, Li-Fang, et al.
Publicado: (2013)

Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells
por: Alli, Elizabeth, et al.
Publicado: (2011)

Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development
por: Huo, Yanying, et al.
Publicado: (2021)

Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumors
por: Choi, Eun Kyung, et al.
Publicado: (2018)

Characterization of primary mammary epithelial cells with loss of BRCA1 at a single cell level
por: Nakles, Rebecca E, et al.
Publicado: (2013)

PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors
por: Bai, Feng, et al.
Publicado: (2021)

Loss of the BRCA1-Interacting Helicase BRIP1 Results in Abnormal Mammary Acinar Morphogenesis
por: Daino, Kazuhiro, et al.
Publicado: (2013)

ZNF146/OZF and ZNF507 target LINE-1 sequences
por: Creamer, Kevin M, et al.
Publicado: (2022)

ZBRK1, a novel tumor suppressor, activates VHL gene transcription through formation of a complex with VHL and p300 in renal cancer
por: Chen, Ke, et al.
Publicado: (2015)

Regulation of progesterone receptor signaling by BRCA1 in mammary cancer
por: Katiyar, Pragati, et al.
Publicado: (2006)

In Vitro Repression of Brca1-associated RING Domain Gene, Bard1, Induces Phenotypic Changes in Mammary Epithelial Cells
por: Irminger-Finger, Irmgard, et al.
Publicado: (1998)

Ligand-dependent corepressor contributes to transcriptional repression by C(2)H(2) zinc-finger transcription factor ZBRK1 through association with KRAB-associated protein-1
por: Calderon, Mario R., et al.
Publicado: (2014)

Evidence for accelerated aging in mammary epithelia of women carrying germline BRCA1 or BRCA2 mutations
por: Shalabi, Sundus F., et al.
Publicado: (2021)

Single-cell analysis of somatic mutation burden in mammary epithelial cells of pathogenic BRCA1/2 mutation carriers
por: Sun, Shixiang, et al.
Publicado: (2022)

Effects of BRCA1 Transgene Expression on Murine Mammary Gland Development and Mutagen-Induced Mammary Neoplasia
por: Hoshino, Arichika, et al.
Publicado: (2007)

RANKL/RANK control Brca1 mutation-driven mammary tumors
por: Sigl, Verena, et al.
Publicado: (2016)

ANSYS Tutorial: Release 12.1, Structural and thermal analysis using the ANSYS release 12.1 environment
por: Lawrence, Kent L
Publicado: (2010)

Haploinsufficiency of ZNF251 causes DNA-PKcs-dependent resistance to PARP inhibitors in BRCA1-mutated cancer cells
por: Li, Huan, et al.
Publicado: (2023)

Half-lives of $^{121}$Cs and $^{121}$In isomers
por: Scheidemann, Ø, et al.
Publicado: (1974)

Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds
por: Zimmer, Jutta, et al.
Publicado: (2016)

Relationship between three novel SNPs of BRCA1 and canine mammary tumors
por: SUN, Weidong, et al.
Publicado: (2015)

Role of the BRCA1 gene in stem cells and treatment of mammary gland cancer
por: Rassi, H
Publicado: (2009)

Inhibition of AKT suppresses the initiation and progression of BRCA1-associated mammary tumors
por: Baek, Hye Jung, et al.
Publicado: (2018)

BRCA1 mutation influences progesterone response in human benign mammary organoids
por: Davaadelger, Batzaya, et al.
Publicado: (2019)

MSA1.2.1 - EMI Reference Releases
Publicado: (Octo)

MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell compartments of the mouse mammary gland
por: Wronski, A, et al.
Publicado: (2016)

Sox11 regulates mammary tumour-initiating and metastatic capacity in Brca1-deficient mouse mammary tumour cells
por: Tsang, Siu Man, et al.
Publicado: (2021)

BRCA1 Deficiency: BRCA1 Deficiency Impairs Mitophagy and Promotes Inflammasome Activation and Mammary Tumor Metastasis (Adv. Sci. 6/2020)
por: Chen, Qiang, et al.
Publicado: (2020)

ZNF274 Recruits the Histone Methyltransferase SETDB1 to the 3′ Ends of ZNF Genes
por: Frietze, Seth, et al.
Publicado: (2010)

Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil
por: Maistro, Simone, et al.
Publicado: (2016)

BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer
por: Clark-Knowles, Katherine V., et al.
Publicado: (2010)

Memorandum 121
por: Barloutaud, R
Publicado: (1978)

Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1
por: Wright, Mollie H, et al.
Publicado: (2008)

Embryonic mammary signature subsets are activated in Brca1(-/- )and basal-like breast cancers
por: Zvelebil, Marketa, et al.
Publicado: (2013)

Inhibition of Estrogen Signaling Reduces the Incidence of BRCA1-associated Mammary Tumor Formation
por: Baek, Hye Jung, et al.
Publicado: (2018)

p16(INK4a) suppresses BRCA1-deficient mammary tumorigenesis
por: Scott, Alexandria, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9a2ugrse2sj659p2gdf0rrbmvd